Education

Research Fellowship
National Cancer Institute/NIH (2013)
Medical School
University of Michigan Medical School (2014)
Internship
Santa Clara Valley Medical Center (2015), Transitional Year
Residency
University of North Carolina Hospitals (2019), Radiation Oncology

Research Interest

  • Clinical trials of novel radiation techniques to reduce treatment time, burden, and toxicity
  • Development of biomarkers to help assess response to therapy, guide treatment decisions, and detect early recurrence
  • Investigation of patient-reported outcomes and toxicities related to radiation therapy

Publications

Featured Publications LegendFeatured Publications

Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions.
Moon DH, Lee JM, Noonan AM, Annunziata CM, Minasian L, Houston N, Hays JL, Kohn EC, Br. J. Cancer 2013 Aug 109 4 1072-8

Books

Featured Books Legend Featured Books

Ovarian Cancer. In The Bethesda Handbook of Clinical Oncology

Lee J-M, Buckley de Meritens A, Moon DH, Kohn EC. (2014). Philadelphia, Lippincott Williams & Wilkins

Glioblastoma. In Hypofractionated and Stereotactic Radiation Therapy: A Practical Guide

Moon DH, Zagar TM. (2018). Springer International Publishing

Secondary Malignant (Metastases). In Hypofractionated and Stereotactic Radiation Therapy: A Practical Guide

Moon DH, Zagar TM. (2018). Springer International Publishing

Honors & Awards

  • Pope Clinical Trainee Award, University of North Carolina
    (2019)
  • RSNA Roentgen Resident/Fellow Research Award
    (2019)
  • Society for Translational Oncology Rising Star in Oncology
    (2018)
  • Medical Research Scholars Program, National Institutes of Health
    (2012-2013)
  • J. Griswold and Margery H. Ruth Scholarship, University of Michigan Medical School
    (2009-2013)

Professional Associations/Affiliations

  • American Society for Radiation Oncology (ASTRO)
  • American Society of Clinical Oncology (ASCO)